As the global economy mends, the 2021 growth of Tramadol (INN) will have significant change from previous year. According to our (LP Information) latest study, the global Tramadol (INN) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Tramadol (INN) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Tramadol (INN) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Tramadol (INN) market, reaching US$ million by the year 2028. As for the Europe Tramadol (INN) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Tramadol (INN) players cover CSL Limited, Grnenthal GmbH, Mundipharma, and Hexal AG, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Tramadol (INN) market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
by Standard
Capsule
Injection
Suppositories
Relievers
by Drug-delivery Way
Intravenous
Intramuscular Injection
Subcutaneous Injection
Oral
Anus For Medicine
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Pain Relief
Cancer Pain Relief
Labor Pain
Cold Relief
Cough Relief
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
CSL Limited
Grnenthal GmbH
Mundipharma
Hexal AG
Labopharm
Pliva Pharma
Nippon Shinyaku
Atoz Pharmaceuticals
Rompharm Company
Amneal Pharmaceuticals
Par Pharmaceutical
Kosher Pharmaceuticals
CSPC
Xinhua Pharmaceutical
Tianlong Shiye
Medochemie
Hubei Qianjiang Pharmaceutical
Shiyao Group
Chenxin Pharmaceutical
Southwest Pharmaceutical
Shandong Xinhua Pharmaceutical
Shanghai Hefeng Pharmaceutical
Duoduo Pharmaceutical
EICARE PHARMACEUTICAL
Guizhou Yikang Pharmaceutical